← Back to library
article 2017 8 pages

A Placebo-Controlled Trial of Riboflavin for Enhancement of Ultramarathon Recovery

Martin D. Hoffman, Taylor R. Valentino, Kristin J. Stuempfle, Brandon V. Hassid

Journal
Sports Medicine - Open
DOI
10.1186/s40798-017-0081-4
Publication type
Original Research
Population
ultramarathon runners
View on DOI ↗

Abstract

Background

Riboflavin is known to protect tissue from oxidative damage but, to our knowledge, has not been explored as a means to control exercise-related muscle soreness. This study investigated whether acute ingestion of riboflavin reduces muscle pain and soreness during and after completion of a 161-km ultramarathon and improves functional recovery after the event.

Methods

In this double-blind, placebo-controlled trial, participants of the 2016 161-km Western States Endurance Run were assigned to receive a riboflavin or placebo capsule shortly before the race start and when reaching 90 km. Capsules contained either 100 mg of riboflavin or 95 mg of maltodextrin and 5 mg of 10% ß-carotene. Subjects provided muscle pain and soreness ratings before, during, and immediately after the race and for the 10 subsequent days. Subjects also completed 400-m runs at maximum speed on days 3, 5, and 10 after the race.

Results

For the 32 (18 in the riboflavin group, 14 in the placebo group) race finishers completing the study, muscle pain and soreness ratings during and immediately after the race were found to be significantly lower (p = .043) for the riboflavin group. Analysis of the 400-m run times also showed significantly faster (p 

Description

Riboflavin may reduce muscle pain and enhance recovery in ultramarathon runners.